Name: AstraZeneca doubles down on China with $15 billion investment through 2030
Uploaded: 2026-01-30T20:01:59+08:00
Duration: 6 min
Description: During the UK Prime Minister Starmer's visit to China, CGTN's Guan Xin sat down with AstraZeneca CEO Pascal Soriot to discuss the company’s expanding strategy in China, including its newly announced $15 billion China investment during the visit. Soriot

Language

RSS

Newsletters

Home

China

World

Politics

Business

Sci-Tech

Health

Opinions

Video

Live

Radio

World Asia-Pacific Middle East Europe Americas Africa

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.

I agree

06:01

During the UK Prime Minister Starmer's visit to China, CGTN's Guan Xin sat down with AstraZeneca CEO Pascal Soriot to discuss the company’s expanding strategy in China, including its newly announced $15 billion China investment during the visit. Soriot also outlined how AstraZeneca is engaging with China's innovation ecosystem as the country continues to open up its healthcare and lifesciences sectors.

Open in CGTN APP for better experience

Search Trends